⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IOVA News
Iovance Biotherapeutics, Inc. Common Stock
Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026
globenewswire.com
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Proleukin Market Research Report 2026-2035: Epidemiology, Pipeline Analysis, Industry Insights and More
globenewswire.com
IOVA
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
prnewswire.com
PRME
IOVA
MDGL
DNLI
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
prnewswire.com
PRME
IOVA
MDGL
DNLI
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors
globenewswire.com
BMRN
IOVA
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
globenewswire.com
IOVA
Form 8-K
sec.gov
IOVA
Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
prnewswire.com
IOVA
VIR
CCCC
ONCY
IMCR
Iovance Biotherapeutics to Present at Upcoming Conferences
globenewswire.com
IOVA